- Home
- SNAL vs MYO Comparison
SNAL vs MYO Comparison
Compare SNAL & MYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNAL
- MYO
- Stock Information
- Founded
- SNAL 2000
- MYO 2004
- Country
- SNAL United States
- MYO United States
- Employees
- SNAL N/A
- MYO N/A
- Industry
- SNAL Computer Software: Prepackaged Software
- MYO Industrial Specialties
- Sector
- SNAL Technology
- MYO Health Care
- Exchange
- SNAL Nasdaq
- MYO Nasdaq
- Market Cap
- SNAL 45.1M
- MYO 40.8M
- IPO Year
- SNAL 2022
- MYO 2017
- Fundamental
- Price
- SNAL $1.11
- MYO $0.97
- Analyst Decision
- SNAL
- MYO Strong Buy
- Analyst Count
- SNAL 0
- MYO 3
- Target Price
- SNAL N/A
- MYO $7.83
- AVG Volume (30 Days)
- SNAL 97.1K
- MYO 2.1M
- Earning Date
- SNAL 11-13-2025
- MYO 11-07-2025
- Dividend Yield
- SNAL N/A
- MYO N/A
- EPS Growth
- SNAL N/A
- MYO N/A
- EPS
- SNAL N/A
- MYO N/A
- Revenue
- SNAL $91,041,290.00
- MYO $40,760,091.00
- Revenue This Year
- SNAL $13.87
- MYO $24.69
- Revenue Next Year
- SNAL $26.20
- MYO $20.91
- P/E Ratio
- SNAL N/A
- MYO N/A
- Revenue Growth
- SNAL 24.25
- MYO 93.08
- 52 Week Low
- SNAL $0.64
- MYO $0.80
- 52 Week High
- SNAL $3.42
- MYO $7.17
- Technical
- Relative Strength Index (RSI)
- SNAL 52.74
- MYO 41.86
- Support Level
- SNAL $0.96
- MYO $1.04
- Resistance Level
- SNAL $1.20
- MYO $1.13
- Average True Range (ATR)
- SNAL 0.08
- MYO 0.10
- MACD
- SNAL 0.00
- MYO -0.00
- Stochastic Oscillator
- SNAL 62.50
- MYO 3.88
About SNAL Snail Inc.
Snail Inc is an independent developer and publisher of interactive digital entertainment for consumers around the world, with a portfolio of premium games designed for use on a variety of platforms, including consoles, PC's, and mobile devices. The geographic presence of the company is in the United States and the International market, where the majority of its revenue comes from the United States.
About MYO Myomo Inc.
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).